Millennium Management’s Innate Pharma IPHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.4K | Sell |
11,661
-3,665
| -24% | -$6.41K | ﹤0.01% | 3916 |
|
|
2025
Q1 | $27.3K | Buy |
+15,326
| New | +$27.3K | ﹤0.01% | 3862 |
|
|
2024
Q2 | – | Sell |
-10,579
| Closed | -$30.5K | – | 4215 |
|
|
2024
Q1 | $30.5K | Sell |
10,579
-1,423
| -12% | -$4.1K | ﹤0.01% | 3942 |
|
|
2023
Q4 | $33.6K | Sell |
12,002
-34,971
| -74% | -$97.9K | ﹤0.01% | 3850 |
|
|
2023
Q3 | $119K | Sell |
46,973
-2,477
| -5% | -$6.27K | ﹤0.01% | 3740 |
|
|
2023
Q2 | $155K | Sell |
49,450
-12,449
| -20% | -$39.1K | ﹤0.01% | 3780 |
|
|
2023
Q1 | $176K | Sell |
61,899
-9,785
| -14% | -$27.8K | ﹤0.01% | 3903 |
|
|
2022
Q4 | $267K | Buy |
71,684
+57,050
| +390% | +$212K | ﹤0.01% | 3960 |
|
|
2022
Q3 | $29K | Sell |
14,634
-2,222
| -13% | -$4.4K | ﹤0.01% | 4928 |
|
|
2022
Q2 | $46K | Sell |
16,856
-8,259
| -33% | -$22.5K | ﹤0.01% | 4848 |
|
|
2022
Q1 | $84K | Sell |
25,115
-29,906
| -54% | -$100K | ﹤0.01% | 4897 |
|
|
2021
Q4 | $252K | Buy |
55,021
+27,903
| +103% | +$128K | ﹤0.01% | 4517 |
|
|
2021
Q3 | $167K | Sell |
27,118
-19,649
| -42% | -$121K | ﹤0.01% | 4786 |
|
|
2021
Q2 | $155K | Sell |
46,767
-2,967
| -6% | -$9.83K | ﹤0.01% | 4769 |
|
|
2021
Q1 | $214K | Sell |
49,734
-4,963
| -9% | -$21.4K | ﹤0.01% | 4125 |
|
|
2020
Q4 | $224K | Sell |
54,697
-17,960
| -25% | -$73.6K | ﹤0.01% | 3670 |
|
|
2020
Q3 | $288 | Hold |
72,657
| – | – | ﹤0.01% | 3090 |
|
|
2020
Q2 | $530K | Hold |
72,657
| – | – | ﹤0.01% | 2710 |
|
|
2020
Q1 | $485K | Sell |
72,657
-1,585
| -2% | -$10.6K | ﹤0.01% | 2318 |
|
|
2019
Q4 | $477K | Buy |
+74,242
| New | +$477K | ﹤0.01% | 2773 |
|